...
sny-img

Sanofi ADR, Common Stock

SNY

NSQ

$47.71

+$0.21

(0.44%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$120.92B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
24.873
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.43M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
4.33%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.45
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$45.22 L
$58.97 H
$47.71

About Sanofi ADR, Common Stock

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameSNYSectorS&P500
1-Week Return1.94%-2.12%-3%
1-Month Return-0.15%-3.42%-0.73%
3-Month Return-17.21%-11.13%2.87%
6-Month Return1.84%-5.74%7.17%
1-Year Return-1.04%3.97%25.31%
3-Year Return-2.57%1.05%28.38%
5-Year Return-5.62%34.37%81.89%
10-Year Return3.81%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue37.63B37.37B39.17B45.39B46.03B[{"date":"2019-12-31","value":81.75,"profit":true},{"date":"2020-12-31","value":81.18,"profit":true},{"date":"2021-12-31","value":85.1,"profit":true},{"date":"2022-12-31","value":98.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue11.98B12.16B12.26B13.69B14.24B[{"date":"2019-12-31","value":84.15,"profit":true},{"date":"2020-12-31","value":85.4,"profit":true},{"date":"2021-12-31","value":86.08,"profit":true},{"date":"2022-12-31","value":96.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit25.65B25.21B26.92B31.70B31.80B[{"date":"2019-12-31","value":80.67,"profit":true},{"date":"2020-12-31","value":79.29,"profit":true},{"date":"2021-12-31","value":84.66,"profit":true},{"date":"2022-12-31","value":99.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin68.17%67.47%68.72%69.83%69.07%[{"date":"2019-12-31","value":97.61,"profit":true},{"date":"2020-12-31","value":96.61,"profit":true},{"date":"2021-12-31","value":98.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.91,"profit":true}]
Operating Expenses18.47B17.32B17.77B19.81B23.94B[{"date":"2019-12-31","value":77.16,"profit":true},{"date":"2020-12-31","value":72.34,"profit":true},{"date":"2021-12-31","value":74.23,"profit":true},{"date":"2022-12-31","value":82.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income3.05B8.08B8.13B16.79B7.88B[{"date":"2019-12-31","value":18.17,"profit":true},{"date":"2020-12-31","value":48.12,"profit":true},{"date":"2021-12-31","value":48.39,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":46.89,"profit":true}]
Total Non-Operating Income/Expense(4.43B)(313.00M)(656.00M)(400.00M)(1.36B)[{"date":"2019-12-31","value":-442900000000,"profit":false},{"date":"2020-12-31","value":-31300000000,"profit":false},{"date":"2021-12-31","value":-65600000000,"profit":false},{"date":"2022-12-31","value":-40000000000,"profit":false},{"date":"2023-12-31","value":-136100000000,"profit":false}]
Pre-Tax Income2.75B13.80B7.80B10.49B7.15B[{"date":"2019-12-31","value":19.94,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":56.49,"profit":true},{"date":"2022-12-31","value":75.99,"profit":true},{"date":"2023-12-31","value":51.82,"profit":true}]
Income Taxes121.00M1.81B1.56B2.01B1.60B[{"date":"2019-12-31","value":6.03,"profit":true},{"date":"2020-12-31","value":90.38,"profit":true},{"date":"2021-12-31","value":77.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.86,"profit":true}]
Income After Taxes2.63B11.99B6.24B8.48B5.55B[{"date":"2019-12-31","value":21.94,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":52.04,"profit":true},{"date":"2022-12-31","value":70.75,"profit":true},{"date":"2023-12-31","value":46.29,"profit":true}]
Income From Continuous Operations2.94B12.35B6.28B6.83B5.44B[{"date":"2019-12-31","value":23.79,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":50.84,"profit":true},{"date":"2022-12-31","value":55.33,"profit":true},{"date":"2023-12-31","value":44.02,"profit":true}]
Income From Discontinued Operations(101.00M)----[{"date":"2019-12-31","value":-10100000000,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income2.75B12.29B6.22B8.37B5.40B[{"date":"2019-12-31","value":22.4,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":50.62,"profit":true},{"date":"2022-12-31","value":68.09,"profit":true},{"date":"2023-12-31","value":43.92,"profit":true}]
EPS (Diluted)3.173.413.874.325.77[{"date":"2019-12-31","value":54.94,"profit":true},{"date":"2020-12-31","value":59.1,"profit":true},{"date":"2021-12-31","value":67.07,"profit":true},{"date":"2022-12-31","value":74.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SNY
ROA (LTM) 4.16%
ROE (LTM) 5.82%

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SNY
Trailing PE 25.13
Forward PE 10.48
P/S (TTM) 2.49
P/B 1.56
EV/R 2.69
EV/Ebitda 14.54
PEG 0.73

FAQs

What is Sanofi ADR share price today?

Sanofi ADR (SNY) share price today is $47.71

Can Indians buy Sanofi ADR shares?

Yes, Indians can buy shares of Sanofi ADR (SNY) on Vested. To buy Sanofi ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SNY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Sanofi ADR be purchased?

Yes, you can purchase fractional shares of Sanofi ADR (SNY) via the Vested app. You can start investing in Sanofi ADR (SNY) with a minimum investment of $1.

How to invest in Sanofi ADR shares from India?

You can invest in shares of Sanofi ADR (SNY) via Vested in three simple steps:

  • Click on Sign Up or Invest in SNY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Sanofi ADR shares
What is Sanofi ADR 52-week high and low stock price?

The 52-week high price of Sanofi ADR (SNY) is $58.97. The 52-week low price of Sanofi ADR (SNY) is $45.22.

What is Sanofi ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Sanofi ADR (SNY) is 24.873

What is Sanofi ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Sanofi ADR (SNY) is 1.56

What is Sanofi ADR dividend yield?

The dividend yield of Sanofi ADR (SNY) is 4.33%

What is the Market Cap of Sanofi ADR?

The market capitalization of Sanofi ADR (SNY) is $120.92B

What is Sanofi ADR’s stock symbol?

The stock symbol (or ticker) of Sanofi ADR is SNY

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top